The anticancer activity of Prozac was largely confirmed in the SKNAS model, although the decrease in metastases formation in the liver did not reach statistical significance (Fig. 4d ).
← all excerpts
Repurposing a psychoactive drug for children with cancer: p27<sup>Kip1</sup>-dependent inhibition of metastatic neuroblastomas by Prozac.
1
—
—